Complete Filing Data
Ategrity Specialty Insurance Co Holdings reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $614.86 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Ategrity Specialty Insurance Co Holdings did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Net Income * | $74.0M | $47.1M |
| Revenues | $424.3M | $343.8M |
| Other Comprehensive Income Loss Net Of Tax | $6.2M | $7.4M |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $6.2M | $7.4M |
| Net Income Loss Attributable To Noncontrolling Interest | $2.1M | $6.9M |
| Interest Expense | $1.4M | $2.0M |
| Income Tax Expense Benefit | $19.8M | $12.3M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $95.9M | $66.3M |
| Comprehensive Income Net Of Tax | $80.2M | $54.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Net Income * | $22.7M | $17.6M | $12.9M | $4.9M |
| Revenues | $116.1M | $101.8M | $88.7M | $74.4M |
| Other Comprehensive Income Loss Net Of Tax | $5.9M | $152.0K | $10.9M | $840.0K |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $5.9M | $152.0K | $10.9M | $840.0K |
| Net Income Loss Attributable To Noncontrolling Interest | $952.0K | -$5.0K | $2.3M | -$828.0K |
| Interest Expense | $392.0K | $447.0K | $480.0K | $544.0K |
| Income Tax Expense Benefit | $6.1M | $4.7M | $3.3M | $1.2M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $29.7M | $22.3M | $18.5M | $5.3M |
| Comprehensive Income Net Of Tax | $28.6M | $17.8M | $23.7M | $5.8M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Stockholders Equity * | $614.3M | $398.3M | $322.2M |
| Premiums Receivable Allowance For Doubtful Accounts | $8.8M | $5.9M | $3.0M |
| Deferred Policy Acquisition Costs | $30.2M | $21.6M | $23.2M |
| Liability For Claims And Claims Adjustment Expense | $502.2M | $403.6M | $320.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $29.7M | $26.6M | $264.6M |
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 | $212.1M | $175.2M | |
| Gain Loss On Investments | $12.7M | $28.1M | |
| Retained Earnings Accumulated Deficit | $108.6M | $34.6M | |
| Reinsurance Payable | $31.1M | $27.2M | |
| Premiums Receivable At Carrying Value | $75.2M | $53.5M | |
| Preferred Stock Value | $0.00 | $0.00 | |
| Other Short Term Investments | $220.2M | $52.6M | |
| Other Long Term Investments | $280.0K | $280.0K | |
| Other Liabilities | $2.6M | $4.3M | |
| Other Assets | $12.7M | $25.4M | |
| Minority Interest | $550.0K | $500.0K | |
| Liabilities And Stockholders Equity | $1.47B | $1.12B | |
| Liabilities | $859.5M | $724.6M | |
| Investments | $1.08B | $775.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|
| Stockholders Equity * | $588.6M | $559.7M | $427.3M | $364.9M | $338.8M | $333.7M |
| Premiums Receivable Allowance For Doubtful Accounts | $7.5M | $6.1M | $4.4M | $5.7M | $4.2M | $3.5M |
| Deferred Policy Acquisition Costs | $30.1M | $27.6M | $24.7M | $23.9M | $24.4M | $23.5M |
| Liability For Claims And Claims Adjustment Expense | $487.2M | $451.5M | $380.7M | $362.7M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $34.3M | $23.5M | $124.2M | $97.1M | ||
| Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 | $56.2M | $50.4M | $45.2M | $44.1M | ||
| Gain Loss On Investments | $9.2M | $1.4M | $8.8M | -$4.2M | ||
| Retained Earnings Accumulated Deficit | $83.3M | $60.7M | ||||
| Reinsurance Payable | $25.0M | $38.1M | ||||
| Premiums Receivable At Carrying Value | $77.9M | $89.2M | ||||
| Preferred Stock Value | $0.00 | $0.00 | ||||
| Other Short Term Investments | $223.0M | $251.9M | ||||
| Other Long Term Investments | $280.0K | $280.0K | ||||
| Other Liabilities | $3.2M | $3.4M | ||||
| Other Assets | $9.2M | $12.7M | ||||
| Minority Interest | $1.4M | $484.0K | ||||
| Liabilities And Stockholders Equity | $1.45B | $1.36B | ||||
| Liabilities | $856.4M | $803.0M | ||||
| Investments | $1.03B | $955.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Increase Decrease In Unearned Premiums Net | -$62.9M | -$8.6M |
| Proceeds From Sale Of Securities Sold Not Yet Purchased | $0.00 | -$348.0K |
| Proceeds From Sale Of Other Assets Investing Activities | $0.00 | $415.0K |
| Proceeds From Sale Of Available For Sale Securities Debt | $290.8M | $99.4M |
| Proceeds From Sale Of Alternative Investments | $106.2M | $414.0K |
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | $8.7M | $17.7M |
| Proceeds From Issuance Of Common Stock | $121.7M | $0.00 |
| Proceeds From Contributed Capital | $22.7M | $0.00 |
| Payments To Fund Longterm Loans To Related Parties | $93.0M | $0.00 |
| Payments To Acquire Marketable Securities | $63.8M | $39.2M |
| Payments To Acquire Available For Sale Securities Debt | $338.4M | $389.3M |
| Payments To Acquire Alternative Investments | $10.0M | $0.00 |
| Payments Of Stock Issuance Costs | $4.7M | $0.00 |
| Payments Of Capital Distribution | $6.9M | $414.0K |
| Payments For Repurchase Of Common Stock | $2.7M | $0.00 |
| Payments For Proceeds From Short Term Investments | $168.2M | $53.4M |
| Net Cash Provided By Used In Operating Activities | $147.2M | $125.6M |
| Net Cash Provided By Used In Investing Activities | -$274.2M | -$363.3M |
| Net Cash Provided By Used In Financing Activities | $130.1M | -$414.0K |
| Share Based Compensation | $1.0M | $2.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Increase Decrease In Unearned Premiums Net | -$13.8M | -$30.3M | -$3.0M | -$12.1M |
| Proceeds From Sale Of Securities Sold Not Yet Purchased | ||||
| Proceeds From Sale Of Other Assets Investing Activities | ||||
| Proceeds From Sale Of Available For Sale Securities Debt | ||||
| Proceeds From Sale Of Alternative Investments | ||||
| Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities | ||||
| Proceeds From Issuance Of Common Stock | ||||
| Proceeds From Contributed Capital | ||||
| Payments To Fund Longterm Loans To Related Parties | ||||
| Payments To Acquire Marketable Securities | ||||
| Payments To Acquire Available For Sale Securities Debt | ||||
| Payments To Acquire Alternative Investments | ||||
| Payments Of Stock Issuance Costs | ||||
| Payments Of Capital Distribution | ||||
| Payments For Repurchase Of Common Stock | ||||
| Payments For Proceeds From Short Term Investments | ||||
| Net Cash Provided By Used In Operating Activities | ||||
| Net Cash Provided By Used In Investing Activities | ||||
| Net Cash Provided By Used In Financing Activities | ||||
| Share Based Compensation |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 44.7M | 36.6M |
| Weighted Average Number Of Diluted Shares Outstanding | 46.2M | 36.6M |
| Earnings Per Share Diluted | $1.58 | $1.28 |
| Earnings Per Share Basic | $1.64 | $1.28 |
| Preferred Stock Shares Authorized | 100.0M | 100.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
| Common Stock Shares Authorized | 500.0M | 500.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 |
| Common Stock Shares Outstanding | 48.1M | 38.4M |
| Common Stock Shares Issued | 48.1M | 38.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 48.1M | 42.1M | 36.2M | 36.2M | |
| Weighted Average Number Of Diluted Shares Outstanding | 50.0M | 43.6M | 36.2M | 36.2M | |
| Earnings Per Share Diluted | $0.45 | $0.39 | $0.36 | $0.14 | |
| Earnings Per Share Basic | $0.47 | $0.40 | $0.36 | $0.14 | |
| Preferred Stock Shares Authorized | 100.0M | 100.0M | 100.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | ||
| Common Stock Shares Outstanding | 48.1M | 48.1M | 40.4M | ||
| Common Stock Shares Issued | 48.1M | 48.1M | 40.4M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 |
|---|---|---|
| Underwriting Acquisition And Insurance Expenses | $113.3M | $98.6M |
| Premiums Written Net | $424.6M | $299.2M |
| Premiums Written Gross | $581.5M | $437.0M |
| Premiums Earned Net | $361.7M | $290.6M |
| Other Income | $1.0M | $95.0K |
| Other Expenses | $1.6M | $1.7M |
| Net Investment Income | $42.4M | $24.0M |
| Fee Income | $6.6M | $918.0K |
| Ceded Premiums Written | $156.9M | $137.8M |
| Benefits Losses And Expenses | $328.4M | $277.6M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.0M | $2.0M |
| Security Owned And Sold Not Yet Purchased Security Sold Not Yet Purchased Cost | $0.00 | $932.0K |
| Security Owned And Sold Not Yet Purchased Fair Value Security Sold Not Yet Purchased | $0.00 | $930.0K |
| Reinsurance Recoverables On Paid And Unpaid Losses | $150.4M | $133.6M |
| Reinsurance Recoverables Allowance | $0.00 | $0.00 |
| Purchases To Cover Securities Sold Not Yet Purchased | $0.00 | -$1.3M |
| Prepaid Reinsurance Premiums | $2.9M | $3.9M |
| Interest Paid Net | $1.7M | $2.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Underwriting Acquisition And Insurance Expenses | $29.1M | $28.4M | $24.5M | $24.3M |
| Premiums Written Net | $107.5M | $117.3M | $75.9M | $84.8M |
| Premiums Written Gross | $143.9M | $167.5M | $110.6M | $126.6M |
| Premiums Earned Net | $93.7M | $86.9M | $72.9M | $72.6M |
| Other Income | $25.0K | $28.0K | $24.0K | $24.0K |
| Other Expenses | $659.0K | $161.0K | $64.0K | $56.0K |
| Net Investment Income | $11.0M | $11.9M | $6.8M | $5.7M |
| Fee Income | $2.2M | $1.5M | $249.0K | $191.0K |
| Ceded Premiums Written | $36.3M | $50.2M | $34.6M | $41.8M |
| Benefits Losses And Expenses | $86.4M | $79.5M | $70.2M | $69.0M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $268.0K | $357.0K | $81.0K | $81.0K |
| Security Owned And Sold Not Yet Purchased Security Sold Not Yet Purchased Cost | $0.00 | $0.00 | ||
| Security Owned And Sold Not Yet Purchased Fair Value Security Sold Not Yet Purchased | $0.00 | $0.00 | ||
| Reinsurance Recoverables On Paid And Unpaid Losses | $165.2M | $155.4M | ||
| Reinsurance Recoverables Allowance | $0.00 | $0.00 | ||
| Purchases To Cover Securities Sold Not Yet Purchased | ||||
| Prepaid Reinsurance Premiums | $7.5M | $6.7M | ||
| Interest Paid Net |
Most recent annual filing with the SEC: March 6, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.